Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible <em>Staphylococcus aureus</em>: A Systematic Review and Meta-Analysis
(1) Background: Ceftriaxone is a potential alternative for the treatment of methicillin-susceptible <i>Staphylococcus aureus</i> (MSSA) bloodstream infections (BSIs) in acute care and outpatient parenteral antimicrobial therapy (OPAT) settings. We evaluated the effectiveness and safety o...
Main Authors: | Yazed Saleh Alsowaida, Gregorio Benitez, Khalid Bin Saleh, Thamer A. Almangour, Fadi Shehadeh, Eleftherios Mylonakis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/3/375 |
Similar Items
-
Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy
by: Beatriz Fernández-Rubio, et al.
Published: (2023-02-01) -
Polymicrobial methicillin-resistant Staphylococcus aureus bloodstream infections
by: Angelica Escalona, et al.
Published: (2024-11-01) -
A case of ceftriaxone-induced immune haemolytic anaemia in an ambulatory care setting
by: Rakhee Mistry, et al.
Published: (2024-01-01) -
Antibiotic Stewardship in <i>Staphylococcus aureus</i> Bloodstream Infection Treatment—Analysis Based on 29,747 Patients from One Hospital
by: Grzegorz Ziółkowski, et al.
Published: (2020-06-01) -
Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for <i>Staphylococcus aureus</i> Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort
by: Nerea Castillo-Fernández, et al.
Published: (2023-01-01)